A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

This study has been completed.

Study NCT00650624 Information provided by Pfizer

First Received: March 31, 2008 Last Updated: April 7, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2004
Estimated Primary Completion Date:	No date given